Automated Cell, Inc.
Antibody therapeutics firm receives $100,000 investment
Published in Oncology Business Week, May 30th, 2004
Automated Cell, Inc., (ACI), a company focused on the development of antibody therapeutics for the treatment of cancer, and the Pittsburgh Life Sciences Greenhouse (PLSG), a partnership to put the region's life sciences industry on a fast track for growth, announced that PLSG, through its affiliate, the Pittsburgh Biomedical Development Corporation (PBDC), has invested $100,000 in funds to ACI.
The early stage life sciences venture has created an innovative approach in which the starting point for drug discovery is the antibody itself, as opposed to more common drug discovery initiatives that begin with a "drug target."
The PBDC investment will be...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- Alliance for Cancer Gene Therapy
$4 million in research grants awarded - Altarex Corp.
MAb prolongs disease-free survival in optimal chemosensitive patients - Aptamera, Inc.
Mark C. Rogers becomes chairman of oncology drug-development company - Ardais Corporation
Biorepository to be launched at Duke for clinical research in cancer - AstraZeneca
Genetic mutations of EGFR-TK confer responsiveness to Iressa - CancerVax Corporation
Preclinical data support anti-angiogenic effects of monoclonal antibody - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
